Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allander Biotechnologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
Allander Biotechnologies

Allander Biotechnologies

Allander Biotech: Pioneering tissue regeneration solutions through innovative R&D and drug development.

HQ
Aurora, CO, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to address unmet medical needs in tissue regeneration, Allander Biotechnologies focuses on innovative R&D and drug development. The company specializes in creating proprietary biologics that promote tissue regeneration and exhibit anti-inflammatory properties, primarily delivered through local or topical applications. Their market focus includes medical indications related to excessive inflammation and tissue regeneration defects.

Allander Biotechnologies has garnered attention for its pioneering approach in the biotech industry. The team comprises experts in regenerative medicine and drug development, although specific notable affiliated individuals and investors are not publicly detailed. The company's key achievements include advancing the science of tissue regeneration and contributing to potential therapeutic solutions for chronic conditions. Their impact lies in the promise of improved patient outcomes through cutting-edge regenerative therapies.

Allander Biotechnologies - Similar Companies

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Amplifica logo

Amplifica

amplificabio.com

Endogena Therapeutics logo

Endogena Therapeutics

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Antria logo

Antria

antria.org

Therini Bio logo

Therini Bio

therinibio.com

Regenemed logo

Regenemed

regenemed.com

GentiBio logo

GentiBio

gentibio.com

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Histogen logo

Histogen

histogen.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Humabiologics logo

Humabiologics

humabiologics.com

Amplicore logo

Amplicore

Aliva Biopharmaceuticals logo

Aliva Biopharmaceuticals

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Allander Biotechnologies - Quick Facts

Who are Allander Biotechnologies' competitors?

Companies similar to Allander Biotechnologies include Ampersand Biomedicines, Amplifica, Endogena Therapeutics and Andson Biotech.

When was Allander Biotechnologies founded?

Allander Biotechnologies was founded in 2014.

Where is Allander Biotechnologies' headquarters located?

Allander Biotechnologies' headquarters is located in Aurora, CO, US.

When was Allander Biotechnologies' last funding round?

Allander Biotechnologies' most recent funding round was for $1M (USD) in October 2023.

How much has Allander Biotechnologies raised to-date?

As of Oct 11, 2023, Allander Biotechnologies has raised a total of $1M (USD).

How many employees does Allander Biotechnologies have?

Allander Biotechnologies has 2 employees as of Feb 5, 2024.

Allander Biotechnologies - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biologics
  • Drug Development
Tags
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified